0001225208-22-006817.txt : 20220510
0001225208-22-006817.hdr.sgml : 20220510
20220510205447
ACCESSION NUMBER: 0001225208-22-006817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220507
FILED AS OF DATE: 20220510
DATE AS OF CHANGE: 20220510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wood Larry L
CENTRAL INDEX KEY: 0001440660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 22911786
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0306
4
2022-05-07
0001099800
Edwards Lifesciences Corp
EW
0001440660
Wood Larry L
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, TAVR
Common Stock
2022-05-07
4
F
0
679.0000
100.5200
D
200820.0338
D
Common Stock
2022-05-08
4
M
0
13256.0000
0
A
214076.0338
D
Common Stock
2022-05-08
4
F
0
8007.0000
100.5200
D
206069.0338
D
Common Stock
2022-05-10
4
M
0
7242.0000
36.7500
A
213311.0338
D
Common Stock
2022-05-10
4
S
0
2674.0000
95.7106
D
210637.0338
D
Common Stock
2022-05-10
4
S
0
4568.0000
96.3771
D
206069.0338
D
Common Stock
495.8921
I
401(k)
Performance Rights
2022-05-08
4
M
0
13256.0000
0.0000
D
2022-05-08
2026-05-07
Common Stock
13256.0000
0.0000
D
Employee Stock Option (Right to Acquire)
36.7500
2022-05-10
4
M
0
7242.0000
0.0000
D
2018-05-11
2024-05-10
Common Stock
7242.0000
50688.0000
D
On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.
This transaction was executed in multiple trades at prices ranging from $95.16 to $96.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $96.18 to $96.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2022-05-10